Principal Financial Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $32.5M | Sell |
|
|||||
|
2025
Q2 | $30.6M | Sell |
|
|||||
|
2025
Q1 | $27.5M | Sell |
|
|||||
|
2024
Q4 | $34.5M | Sell |
|
|||||
|
2024
Q3 | $29.2M | Sell |
|
|||||
|
2024
Q2 | $51.5M | Sell |
|
|||||
|
2024
Q1 | $57.7M | Buy |
|
|||||
|
2023
Q4 | $55.1M | Buy |
|
|||||
|
2023
Q3 | $42.5M | Sell |
|
|||||
|
2023
Q2 | $36.2M | Sell |
|
|||||
|
2023
Q1 | $39.2M | Sell |
|
|||||
|
2022
Q4 | $47.9M | Buy |
|
|||||
|
2022
Q3 | $41.3M | Sell |
|
|||||
|
2022
Q2 | $38.3M | Buy |
|
|||||
|
2022
Q1 | $30.5M | Sell |
|
|||||
|
2021
Q4 | $28M | Sell |
|
|||||
|
2021
Q3 | $31.8M | Sell |
|
|||||
|
2021
Q2 | $32.5M | Buy |
|
|||||
|
2021
Q1 | $31.9M | Buy |
|
|||||
|
2020
Q4 | $1.08M | Sell |
|
|||||
|
2020
Q3 | $1.12M | Sell |
|
|||||
|
2020
Q2 | $1.67M | Buy |
|
|||||
|
2020
Q1 | $893K | Buy |
|
|||||
|
2019
Q4 | $1.07M | Sell |
|
|||||
|
2019
Q3 | $5.14M | Buy |
|
|||||
|
2019
Q2 | $4.62M | Buy |
|
|||||
|
2019
Q1 | $4.78M | Buy |
|
|||||
|
2018
Q4 | $3.87M | Sell |
|
|||||
|
2018
Q3 | $10.3M | Sell |
|
|||||
|
2018
Q2 | $9.05M | Buy |
|
|||||
|
2018
Q1 | $6.55M | Buy |
|
|||||
|
2017
Q4 | $6.03M | Buy |
|
|||||
|
2017
Q3 | $4.71M | Sell |
|
|||||
|
2017
Q2 | $3.57M | Buy |
|
|||||
|
2017
Q1 | $3.29M | Sell |
|
|||||
|
2016
Q4 | $2.95M | Buy |
|
|||||
|
2016
Q3 | $3.58M | Sell |
|
|||||
|
2016
Q2 | $6.97M | Sell |
|
|||||
|
2016
Q1 | $6.36M | Buy |
|
|||||
|
2015
Q4 | $9.06M | Buy |
|
|||||
|
2015
Q3 | $6.36M | Buy |
|
|||||
|
2015
Q2 | $703K | Buy |
|
|||||
|
2015
Q1 | $480K | Sell |
|
|||||
|
2014
Q4 | $274K | Sell |
|
|||||
|
2014
Q3 | $218K | Hold |
|
|||||
|
2014
Q2 | $207K | Sell |
|
|||||
|
2014
Q1 | $295K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $241K | Sell |
|
|||||
|
2013
Q2 | $312K | Buy |
|